Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

Many patients with relapsed or refractory acute myeloid leukemia (AML) do not receive allogeneic hematopoietic cell transplant (alloHCT) because they are unable to achieve a complete remission (CR) after reinduction chemotherapy. Starting in January 2003, we prospectively assigned patients with AML...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Chen, George L., Liu, Hong, Zhang, Yali, Thomas, Julie, Ross, Maureen, Wang, Eunice S., Block, AnneMarie W., Sait, Sheila, Deeb, George, Wallace, Paul, Wetzler, Meir, Hahn, Theresa, McCarthy, Philip L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4292802/
https://ncbi.nlm.nih.gov/pubmed/24867777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.05.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados